Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:02 PM
Ignite Modification Date:
2025-12-25 @ 11:57 AM
NCT ID:
NCT02311361
Group ID:
EG003
Title:
Durvalumab +Tremelimumab +5 Gy in 5 Fractions
Description:
Cohort C/Dose Level C2 Durvalumab +Tremelimumab +5 Gy in 5 fractions
Durvalumab: 10 mg/kg, mg intravenous (IV), every two weeks, or 1500 mg, IV, every four weeks.
Tremelimumab: 75 mg IV, every 4 weeks for 16 weeks
Sterostatic body radiation therapy (SBRT): 8 Gray (Gy) x 1; 5Gy x 5
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
20
Other Number Affected:
20
Other Number At Risk:
20
Study:
NCT02311361
Results Section:
NCT02311361
Adverse Events Module:
NCT02311361